2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors-Reference-Cited by-同舟云学术

2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors

Published:2017-05 Issue:03 Volume:229 Page:147-167
ISSN:0300-8630
Container-title:Klinische Pädiatrie
language:de
Short-container-title:Klin Padiatr

Author:

Simon Thorsten¹,Hero Barbara¹,Schulte Johannes²,Deubzer Hedwig²,Hundsdoerfer Patrick²,von Schweinitz Dietrich³,Fuchs Jörg⁴,Schmidt Matthias⁵,Prasad Vikas⁶,Krug Barbara⁷,Timmermann Beate⁸,Leuschner Ivo⁹,Fischer Matthias¹⁰,Langer Thorsten¹¹,Astrahantseff Kathy²,Berthold Frank¹,Lode Holger¹²,Eggert Angelika²

Affiliation:

1. Department of Pediatric Oncology and Hematology, University Hospital, University of Cologne

2. Department of Pediatric Oncology and Hematology, Charité University Hospital Berlin

3. Department of Pediatric Surgery, Dr. von Hauner’sches Kinderspital, LMU Munich

4. Department of Pediatric Surgery and Pediatric Urology, University Hospital Tübingen

5. Department of Nuclear Medicine, University Hospital, University of Cologne

6. Department of Nuclear Medicine, Charité University Hospital Berlin

7. Department of Radiology, University Hospital, University of Cologne

8. Clinic for Particle Therapy, Westdeutsches Protonentherapiezentrum, University Hospital Essen

9. Kiel Pediatric Tumor Registry, Dept. for Pediatric Pathology, University Hospital of Schleswig-Holstein, Campus Kiel

10. Department of Experimental Pediatric Oncology, University Hospital, University of Cologne

11. Pediatric Oncology and Hematology, University Hospital Schleswig-Holstein, Campus Lübeck

12. Department of Pediatrics and Pediatric Oncology and Hematology, University Medicine Greifswald

Abstract

AbstractThe clinical course of neuroblastoma is more heterogeneous than any other malignant disease. Most low-risk patients experience regression after limited or even no chemotherapy. However, more than half of high-risk patients die from disease despite intensive multimodal treatment. Precise patient characterization at diagnosis is key for risk-adapted treatment. The guidelines presented here incorporate results from national and international clinical trials to produce recommendations for diagnosing and treating neuroblastoma patients in German hospitals outside of clinical trials.

Publisher

Georg Thieme Verlag KG

Subject

Pediatrics, Perinatology, and Child Health

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0043-103086.pdf

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact of molecular genetic testing in pediatric oncology;Meditsinskiy sovet = Medical Council;2024-01-17

2. Image‐guided core‐needle or surgical biopsy for neuroblastoma diagnosis in children: A systematic review and meta‐analysis from the International Society of Pediatric Surgical Oncology (IPSO);Pediatric Blood & Cancer;2023-11-27

3. A multiscale orchestrated computational framework to reveal emergent phenomena in neuroblastoma;Computer Methods and Programs in Biomedicine;2023-11

4. Combined Metabolic and Functional Tumor Volumes on [18F]FDG-PET/MRI in Neuroblastoma Using Voxel-Wise Analysis;Journal of Clinical Medicine;2023-09-15

5. Image‐defined risk factors in localized thoracic neuroblastoma and ganglioneuroma;Pediatric Blood & Cancer;2023-08-03